Claudia Von Arx | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Claudia Von Arx | Medicine and Dentistry | Best Researcher Award

Oncology consultant/Researcher of INT IRCCS Fondazione G. Pascale, Italy.

Claudia Von Arx is a dedicated researcher and medical professional with a wealth of experience in oncology research. She completed her medical degree at the University of Naples “Federico II” and subsequently specialized in Medical Oncology. Claudia pursued her passion for research by undertaking a PhD at Imperial College London, focusing on the development of recombinant OPCML tumor suppressor protein as a therapy for ovarian cancer. With extensive experience as a clinical research fellow at prestigious institutions like Imperial College London and INT IRCSS Fondazione G. Pascale of Naples, Claudia has contributed significantly to preclinical and translational research in oncology. Her expertise lies in developing predictive biomarkers, planning and conducting clinical trials, and exploring innovative treatment strategies for various types of cancer. Claudia’s commitment to advancing cancer research and patient care underscores her dedication to improving outcomes in oncology.

Professional Profiles:

Education

Ali Gholizadeh pursued his academic journey with distinction, attaining a Master of Science (2) in Material and Surface Engineering from École Nationale Supérieure d’Arts et Métiers (ENSAM) in 2020. Prior to this, he completed a Master of Science (1) in Mechanical Engineering, with a focus on Fluid Dynamics, also from ENSAM, in 2018. Ali’s educational foundation was laid with a Bachelor of Science in Mechanical Engineering from Shahid Bahonar University of Kerman in 2017. Throughout his academic career, Ali demonstrated exceptional aptitude and dedication, evidenced by his research projects and academic achievements.

Professional Experience

Ali Gholizadeh is an accomplished engineer with a diverse background in research and development. Currently serving as a Research Engineer at the University of Liège, he specializes in the development of innovative chip architectures for biochemical workflows. With previous roles at Fluigent and the Science and Technology Research Center, Ali has honed his skills in microfluidic technologies, CAD design, and data analysis. His academic journey includes a Master’s degree in Material and Surface Engineering from École Nationale Supérieure d’Arts et Métiers and a Bachelor’s degree in Mechanical Engineering from Shahid Bahonar University of Kerman. Throughout his career, Ali has demonstrated a strong commitment to advancing engineering solutions through cutting-edge research and development initiatives.

Research Interest

Ali Gholizadeh’s research interests encompass several areas of engineering, with a primary focus on microfluidic technologies and their applications. He is particularly interested in the design and optimization of microfluidic chips for various biochemical workflows, including sample preparation, analysis, and diagnostics. Additionally, Ali is passionate about exploring novel materials and fabrication techniques to enhance the performance and functionality of microfluidic devices. His research also extends to areas such as lab-on-a-chip systems, high-speed imaging, and instrument interface development. Overall, Ali’s goal is to contribute to the advancement of interdisciplinary research at the intersection of engineering, biology, and medicine, with the ultimate aim of addressing real-world challenges and improving human health.

Award and Honors

Ali Gholizadeh has received several honors and awards in recognition of his contributions to research and academia. Notably, he was selected as a ranked student for participation in a prestigious dual degree program between IUST and ENSAM, where his master’s project received the highest score by the jury. Additionally, he achieved the top 1% rank among 35,000 participants in the nationwide university entrance exam for graduate studies in Mechanical Engineering, earning a full scholarship to study at IUST. These accomplishments highlight Ali’s academic excellence and dedication to his field, positioning him as a promising young researcher in the engineering community.

Research Skills

Ali Gholizadeh possesses a diverse set of research skills that enable him to excel in his field. His expertise includes design and microfabrication of electromechanical instruments and microfluidic chips, along with proficiency in CAD, 3D printing, and software programming for development purposes. He is skilled in data analysis and post-processing, utilizing tools such as MATLAB, Python, and image processing techniques. Additionally, Ali has experience in high-speed imaging and microscopy, contributing to his ability to conduct detailed analysis and observation in his research projects. His critical thinking, problem-solving abilities, and strong teamwork skills further enhance his research capabilities, allowing him to make significant contributions to the advancement of engineering and technology.

Publications

  1. A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial
    • Authors: C. von Arx, G. Della Vittoria Scarpati, L. Cannella, A. Ottaiano, S. Tafuto
    • Journal: ESMO Open
    • Year: 2024
    • Volume: 9
    • Issue: 5
    • Citations: 0
  2. Cancer genetic counselling for hereditary breast cancer in the era of precision oncology
    • Authors: M. Pensabene, A. Calabrese, C. von Arx, R. Caputo, M. De Laurentiis
    • Journal: Cancer Treatment Reviews
    • Year: 2024
    • Volume: 125
    • Citations: 0
  3. Neratinib as adjuvant therapy in patients with HER2 positive breast cancer: expert opinion
    • Authors: R. Caputo, G. Buono, V.D. Lauro, F. Nuzzo, M. De Laurentiis
    • Journal: Future Oncology
    • Year: 2023
    • Volume: 19
    • Issue: 24
    • Pages: 1695–1708
    • Citations: 0
  4. The Complex Management of the Breast Angiosarcoma: A Retrospective Study
    • Authors: L. Cannella, F. Perri, O. Clemente, A. De Chiara, S. Tafuto
    • Journal: Oncology (Switzerland)
    • Year: 2023
    • Volume: 101
    • Issue: 4
    • Pages: 234–239
    • Citations: 1
  5. The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer
    • Authors: C. von Arx, P. De Placido, A. Caltavituro, M. Giuliano, L. Del Mastro
    • Journal: Cancer Treatment Reviews
    • Year: 2023
    • Volume: 113
    • Citations: 17
  6. Male Breast Cancer: From Molecular Genetics to Clinical Management
    • Authors: M. Pensabene, C. Von Arx, M. De Laurentiis
    • Journal: Cancers
    • Year: 2022
    • Volume: 14
    • Issue: 8
    • Pages: 2006
    • Citations: 10
  7. Editorial: The Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer: Challenges and Perspectives
    • Authors: A. Ottaiano, M. Berretta, C. Von Arx, M. Capozzi, M. Caraglia
    • Journal: Frontiers in Oncology
    • Year: 2022
    • Volume: 12
    • Pages: 852445
    • Citations: 1
  8. Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest)
    • Authors: I.M. Modlin, M. Kidd, K. Oberg, I.A. Drozdov, A. Kitz
    • Journal: Annals of Surgical Oncology
    • Year: 2021
    • Volume: 28
    • Issue: 12
    • Pages: 7506–7517
    • Citations: 24
  9. Selinexor and the selective inhibition of nuclear export: A new perspective on the treatment of sarcomas and other solid and non-solid tumors
    • Authors: A.L. Marretta, G. Di Lorenzo, D. Ribera, A. Pizzolorusso, S. Tafuto
    • Journal: Pharmaceutics
    • Year: 2021
    • Volume: 13
    • Issue: 9
    • Pages: 1522
    • Citations: 2
  10. Uptake of trastuzumab biosimilars for the treatment of HER2-positive breast cancer: A real-world experience from a cancer center
    • Authors: M. Piezzo, R. D’aniello, I. Avallone, M. De Laurentiis, P. Maiolino
    • Journal: Pharmaceutics
    • Year: 2021
    • Volume: 13
    • Issue: 5
    • Pages: 684
    • Citations: 3